Moreover, it was determined that in vitro and in vivo studies were required to confirm the biological activity of PCSK9 further and explore the relationship between PCSK9 and immunotherapy in pancreatic cancer. The gene discussed is PCSK9; the disease is pancreatic neoplasm.